Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

CYR61 is a secreted, cysteine-rich, heparin-binding protein encoded by a growth factor-inducible immediate–early gene. Acting as an extracellular, matrix-associated signaling molecule, CYR61 promotes the adhesion of endothelial cells through interaction with the integrin αVβ3and augments growth factor-induced DNA synthesis in the same cell type. In this study, we show that purified CYR61 stimulates directed migration of human microvascular endothelial cells in culture through an αVβ3-dependent pathway and induces neovascularization in rat corneas. Both the chemotactic and angiogenic activities of CYR61 can be blocked by specific anti-CYR61 antibodies. Whereas most human tumor-derived cell lines tested expressCYR61, the gastric adenocarcinoma cell line RF-1 does not. Expression of theCYR61cDNA under the regulation of a constitutive promoter in RF-1 cells significantly enhances the tumorigenicity of these cells as measured by growth in immunodeficient mice, resulting in tumors that are larger and more vascularized than those produced by control RF-1 cells. Taken together, these results identify CYR61 as an angiogenic inducer that can promote tumor growth and vascularization; the results also suggest potential roles for CYR61 in physiologic and pathologic neovascularization.

Bibliography

Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., & Lau, L. F. (1998). CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proceedings of the National Academy of Sciences, 95(11), 6355–6360.

Authors 4
  1. Alexander M. Babic (first)
  2. Maria L. Kireeva (additional)
  3. Tatiana V. Kolesnikova (additional)
  4. Lester F. Lau (additional)
References 51 Referenced 399
  1. 10.1016/S0092-8674(00)81279-9
  2. 10.1006/dbio.1996.0319
  3. 10.1016/B978-0-444-81382-4.50019-0
  4. 10.1146/annurev.bi.60.070191.001433
  5. T P O’Brien, G P Yang, L Sanders, L F Lau Mol Cell Biol 10, 3569–3577 (1990). (10.1128/mcb.10.6.2855-2862.1990) / Mol Cell Biol by O’Brien T P (1990)
  6. G P Yang, L F Lau Cell Growth Differ 2, 351–357 (1991). / Cell Growth Differ by Yang G P (1991)
  7. 10.1128/MCB.16.4.1326
  8. 10.1006/excr.1997.3548
  9. 10.1038/sj.onc.1201572
  10. 10.1074/jbc.273.5.3090
  11. 10.1016/0955-0674(93)90036-P
  12. 10.1056/NEJM199512283332608
  13. 10.1038/nm0195-27
  14. J Folkman Tumor Angiogenesis, eds J Mendelsohn, P M Howley, M A Israel, L A Liotta (Saunders, Philadelphia), pp. 206–232 (1995). / Tumor Angiogenesis by Folkman J (1995)
  15. 10.1016/S0065-230X(08)60862-3
  16. T P O’Brien, L F Lau Cell Growth Differ 3, 645–654 (1992). / Cell Growth Differ by O’Brien T P (1992)
  17. B V Latinkic Ph.D. thesis (Univ. of Illinois, Chicago, 1994). / Ph.D. thesis by Latinkic B V (1994)
  18. 10.1126/science.7512751
  19. 10.1126/science.270.5241.1500
  20. A D Miller, G J Rosman Biotechniques 7, 980–982 (1989). / Biotechniques by Miller A D (1989)
  21. C Baum, P Forster, S Hegewisch-Becker, K Harbers Biotechniques 17, 1058–1062 (1994). / Biotechniques by Baum C (1994)
  22. 10.1016/0003-2697(87)90021-2
  23. E Harlow, D Lane Antibodies: A Laboratory Manual (Cold Spring Harbor Lab Press, Plainview, NY, 1988). / Antibodies: A Laboratory Manual by Harlow E (1988)
  24. 10.1016/0076-6879(91)98044-7
  25. F M Ausubel, R Brent, R E Kingston, D D Moore, J G Seidman, J A Smith, K Struhl Current Protocols in Molecular Biology (Wiley, New York, 1994). / Current Protocols in Molecular Biology by Ausubel F M (1994)
  26. 10.1016/S0021-9258(18)45436-1
  27. 10.1091/mbc.8.12.2449
  28. 10.1016/0304-3835(95)03717-B
  29. C J Marshall, L M Franks, A W Carbonell J Clin Invest 58, 1743–1747 (1977). / J Clin Invest by Marshall C J (1977)
  30. 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
  31. 10.1006/dbio.1997.8766
  32. 10.1016/0014-5793(93)80155-N
  33. 10.1101/gad.8.13.1489
  34. 10.1016/0092-8674(95)90446-8
  35. 10.1016/0378-1119(95)00891-8
  36. 10.1038/386671a0
  37. 10.1016/S0968-0004(97)01074-8
  38. 10.1016/S0092-8674(00)81810-3
  39. J A Varner The Role of Vascular Cell Integrins αvβ3 and αvβ5 in angiogenesis., eds I D Goldberg, E M Rosen (Birkhauser, Basel), pp. 361–390 (1997). / The Role of Vascular Cell Integrins αvβ3 and αvβ5 in angiogenesis. by Varner J A (1997)
  40. 10.1016/S0092-8674(00)80108-7
  41. 10.1016/0143-4004(94)90002-7
  42. 10.1083/jcb.109.5.2471
  43. 10.1210/endo-122-5-1761
  44. 10.1006/dbio.1996.9989
  45. 10.1073/pnas.88.7.2692
  46. 10.1073/pnas.88.17.7768
  47. 10.1073/pnas.86.4.1178
  48. S M Albelda, S A Mette, D A Elder, R Stewart, L Damjanovich, M Herlyn, C A Buck Cancer Res 50, 6757–6764 (1990). / Cancer Res by Albelda S M (1990)
  49. 10.1172/JCI115811
  50. 10.1016/0092-8674(94)90007-8
  51. 10.1007/BF00690295
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:40 a.m.)
Deposited 2 years, 4 months ago (April 22, 2023, 8:26 a.m.)
Indexed 4 minutes ago (Aug. 28, 2025, 11:34 p.m.)
Issued 27 years, 3 months ago (May 26, 1998)
Published 27 years, 3 months ago (May 26, 1998)
Published Online 27 years, 3 months ago (May 26, 1998)
Published Print 27 years, 3 months ago (May 26, 1998)
Funders 0

None

@article{Babic_1998, title={CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth}, volume={95}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.95.11.6355}, DOI={10.1073/pnas.95.11.6355}, number={11}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Babic, Alexander M. and Kireeva, Maria L. and Kolesnikova, Tatiana V. and Lau, Lester F.}, year={1998}, month=may, pages={6355–6360} }